Back
ProQR Therapeutics NV Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
29
PRQR
ProQR Therapeutics NV
Last Price:
1.88
Seasonality Move:
3.03%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight selling pressure.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.16 | Sell |
| 20-day SMA: | 2.24 | Sell |
| 50-day SMA: | 2.15 | Sell |
| 200-day SMA: | 1.77 | Buy |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.18 | Sell |
| 50-day EMA: | 2.15 | Sell |
| 200-day EMA: | 1.95 | Sell |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 37.94 | Sell |
| Chaikin Money Flow: | -42224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.12 - 2.44) | Sell |
| Bollinger Bands (100): | (1.83 - 2.31) | Sell |
ProQR Therapeutics NV Technical Analysis
| Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 1.93 while PRQR 8-day simple moving average is 2.16, which is a Sell signal.
- The stock price of PRQR is 1.93 while ProQR Therapeutics NV 20-day SMA is 2.24, which makes it a Sell.
- ProQR Therapeutics NV 50-day simple moving average is 2.15 while PRQR share price is 1.93, making it a Sell technically.
- PRQR stock price is 1.93 and ProQR Therapeutics NV 200-day simple moving average is 1.77, creating a Buy signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
29
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a Sell
The current ProQR Therapeutics NV [PRQR] share price is $1.93. The Score for PRQR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
157.01M
Price in USD:
1.93
Share Volume:
190.01K
ProQR Therapeutics NV 52-Week Range
52-Week High:
3.29
52-Week Low:
1.11
Sell
29
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?
The ProQR Therapeutics NV stock price is 1.93 USD today. -
Will PRQR stock go up or go down?
ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators -
Is ProQR Therapeutics NV overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 1.93 while PRQR 8-day exponential moving average is 2.11, which is a Sell signal.
- The stock price of PRQR is 1.93 while ProQR Therapeutics NV 20-day EMA is 2.18, which makes it a Sell.
- ProQR Therapeutics NV 50-day exponential moving average is 2.15 while PRQR share price is 1.93, making it a Sell technically.
- PRQR stock price is 1.93 and ProQR Therapeutics NV 200-day simple moving average is 1.95, creating a Sell signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.21 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
- PRQR Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting ProQR Therapeutics NV is a Sell
- ProQR Therapeutics NV Relative Strength Index (RSI) is 37.94, which suggest ProQR Therapeutics NV is oversold
- The Bollinger Bands (25) for ProQR Therapeutics NV is (2.12 - 2.44), which suggest ProQR Therapeutics NV is a Sell
- The Bollinger Bands (100) for ProQR Therapeutics NV is (1.83 - 2.31), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.